R&D Strategies for creating an ecosystem to support early-stage ... Learn how to foster growth for early-stage biotech companies through innovative ecosystem strategies and valuable CDMO collaborations
Market Access Sponsored The stealth market access strategy that’s quietly making man... There is an under-the-radar market access strategy that some manufacturers have implemented, but many others remain unaware of.
Market Access Partner Content The Inaugural Market Access for CNS Therapeutics Summit Has ... The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...
Market Access Looking ahead in 2025 and MHRA reliance International reliance is a mechanism whereby certain medical devices could access the UK market more quickly if they have already been approved by a comparable regulator, rather than under
Market Access Sponsored 12 Questions with Patrick Oliver Patrick Oliver, General Manager of Alfasigma UK and Ireland, brings 36 years of industry expertise to the role.
Market Access Part Two: Navigating the complexities of global market acces... The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.